riluzole has been researched along with Sclerosis, Systemic in 1 studies
Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Riluzole is a new drug representing the first active treatment for amyotrophic lateral sclerosis." | 1.30 | Acute hepatitis after riluzole administration. ( Blanc, P; Camu, W; Larrey, D; Ramos, J; Remy, AJ, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Remy, AJ | 1 |
| Camu, W | 1 |
| Ramos, J | 1 |
| Blanc, P | 1 |
| Larrey, D | 1 |
1 other study available for riluzole and Sclerosis, Systemic
| Article | Year |
|---|---|
Acute hepatitis after riluzole administration.
Topics: Acute Disease; Aged; Chemical and Drug Induced Liver Injury; Excitatory Amino Acid Antagonists; Fema | 1999 |